Viral vectors having reduced virulence
First Claim
Patent Images
1. An expression vector comprising:
- a vaccinia virus with reduced pathogenicity in an animal host, which comprises an E3L gene that has a deletion of the region encoding amino acids 184-190 of the E3L protein and encodes a protein that binds dsRNA; and
exogenous DNA and regulatory elements operably linked thereto.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides recombinant vaccinia virus having a deletion of the region encoding the C-terminal seven amino acids of the E3L gene product and comprising exogenous DNA. Compositions comprising the recombinant vaccinia virus and methods of use thereof are also provided.
16 Citations
6 Claims
-
1. An expression vector comprising:
-
a vaccinia virus with reduced pathogenicity in an animal host, which comprises an E3L gene that has a deletion of the region encoding amino acids 184-190 of the E3L protein and encodes a protein that binds dsRNA; and
exogenous DNA and regulatory elements operably linked thereto. - View Dependent Claims (2, 3, 4)
-
-
5. A method of making a recombinant gene product comprising:
-
subjecting an expression vector comprising;
a vaccinia virus with reduced pathogenicity in an animal host, which comprises an E3L gene that has a deletion of the region encoding amino acids 184-190 of the E3L protein and encodes a protein that binds dsRNA; and
exogenous DNA that encodes a recombinant gene product and regulatory elements operably linked the exogenous DNA, to conditions whereby said recombinant gene product is expressed. - View Dependent Claims (6)
-
Specification